IP Library › Patent Application 16796194
Patent Application
App. No. 16/796,194

ESCALATING DOSING REGIMEN FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/796,194
Abstract

The present invention is drawn to novel topiramate compositions as well as methods for effecting weight loss, e.g., in the treatment of obesity and related conditions, including conditions associated with and/or caused by obesity per se. The present invention features an escalating dosing regimen adapted for the administration of topiramate and optionally a sympathomimetic agent such as phentermine or bupropion, in the treatment of obesity and related conditions.

Claims (3)

1 . A controlled release composition for treating obesity, diabetes, sleep apnea, or a related condition in a subject comprising:

an effective amount of topiramate and phentermine.

2 . A method for effecting weight loss in a subject, comprising administering to the subject continually over a significant period of time a daily dose of phentermine in combination therewith a daily dose of topiramate selected to prevent the loss of effectiveness of phentermine alone.

Assignments (4)
TERMINATION AND RELEASE OF PATENT SECURITY AGREEMENT Recorded Dec 10, 2024
From: IEH BIOPHARMA, LLC
To: VIVUS LLC (F/K/A VIVUS, INC.)
Reel/Frame 069585/0667 →
CHANGE OF NAME Recorded Jul 29, 2021
From: VIVUS, INC.
To: VIVUS LLC
Reel/Frame 057091/0229 →
SECURITY INTEREST Recorded Jan 6, 2021
From: VIVUS, INC.
To: IEH BIOPHARMA, LLC
Reel/Frame 054835/0273 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2020
From: NAJARIAN, THOMAS; TAM, PETER Y.; WILSON, LELAND F.
To: VIVUS, INC.
Reel/Frame 051883/0935 →